Citius Oncology (CTOR) Net Income Growth (3y) (2026)

Citius Oncology (CTOR) Net Income Growth (3y) (2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 51.28%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 2.94%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 4.50%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 68.16%
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 66.11%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -17.90%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -30.70%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -109.16%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 253.53%
10 Citius Oncology 71.02 Mn 68.39 Mn 1.34 Mn -464.51%

Historic Data

Download Data
DateValue
Mar 31, 2026 -464.51%